Division of Clinical Cardiology, A.O.R.N. Sant'Anna e San Sebastiano, Caserta, Italy.
Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Intern Emerg Med. 2018 Dec;13(8):1185-1190. doi: 10.1007/s11739-018-1927-6. Epub 2018 Aug 22.
The perioperative management of a cardiac-patient candidate to non-cardiac surgery (NCS) remains a topic of considerable debate. In recent years, the overall tendency from professional societies has been to delineate how to identify and manage high-risk patients following the best evidence. However, significant concerns persist, especially in the care of intermediate-risk patients (also labeled at "acceptable" risk), who may not fit into the categories of "completely healthy" or "critically ill", but that might still encounter dramatic (and unexpected) perioperative events. The specific interest and main goal of this expert viewpoint pertains to the care of cardiac patients scheduled for NCS, addressing central questions of real-life clinical care that practicing anesthesiologists and cardiologists face daily, discussing recent American College of Cardiology/American Heart Association (ACC/AHA), European Society of Cardiology/European Society of Anaesthesiology (ESC/ESA), and Canadian Cardiovascular Society (CCS) guidelines. The viewpoint aims to discuss few of the important topics pertaining perioperative assessment and management: type of NCS and perioperative cardiac events, risk prediction including testing, and perioperative management of cardiac therapy. The fact that cardiac adverse events have reduced in number mostly due to better preoperative management and prevention should not prompt a reduction in clinical evaluations. While debate remains pertaining the most appropriate way to evaluate patients for NCS within international societies, a comprehensive approach-evaluation best recognized to assess functional and heart status, should be maintained, keeping into consideration the surgical procedure and global health management.
心脏患者接受非心脏手术(NCS)的围手术期管理仍然是一个颇具争议的话题。近年来,专业协会的总体趋势是根据最佳证据来确定和管理高危患者。然而,仍存在重大关切,尤其是在对中危患者(也标记为“可接受”风险)的护理方面,这些患者可能不符合“完全健康”或“病危”的类别,但仍可能在围手术期遇到剧烈(和意外)的事件。这个专家观点的具体关注点和主要目标是心脏患者接受 NCS 的护理,针对实践麻醉师和心脏病专家每天面临的实际临床护理的核心问题进行讨论,讨论最近的美国心脏病学会/美国心脏协会(ACC/AHA)、欧洲心脏病学会/欧洲麻醉学会(ESC/ESA)和加拿大心血管学会(CCS)指南。该观点旨在讨论一些与围手术期评估和管理相关的重要话题:NCS 类型和围手术期心脏事件、风险预测包括测试,以及心脏治疗的围手术期管理。心脏不良事件数量的减少主要归因于更好的术前管理和预防,这不应促使临床评估的减少。虽然在国际社会中,对于评估患者接受 NCS 的最合适方法仍存在争议,但应保持一种全面的评估方法,这种方法最好被认可为评估功能和心脏状况,同时考虑手术程序和全球健康管理。